Navigation Links
Perrigo Company Announces Quarterly Dividend
Date:5/6/2009

ALLEGAN, Mich., May 6 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that its Board of Directors declared a quarterly dividend of $0.055 per share, payable on June 16, 2009 to shareholders of record on May 29, 2009.

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products. The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of manufacturing facilities are the United States, Israel, Mexico and the United Kingdom. Visit Perrigo on the Internet (http://www.perrigo.com).


'/>"/>
SOURCE Perrigo Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Perrigo Announces FDA Approval for Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion)
2. Perrigo Begins Shipments of Ibuprofen PM
3. Perrigo Reports Record Second Quarter Sales
4. Perrigo Company Announces Quarterly Dividend
5. Perrigo Company Appointed Generic Distributor by Medimetriks Pharmaceuticals
6. Perrigo Company Will Release Second Quarter Fiscal Year 2009 Results on February 3, 2009
7. Perrigo Company to Present at the 27th Annual JPMorgan Healthcare Conference
8. Perrigo Announces FDA Final Approval for Ibuprofen PM
9. Perrigo Settles Desloratadine Patent Litigation
10. Perrigo Acknowledges Settlement of NASACORT(R) AQ Nasal Spray Patent Litigation
11. Perrigo Announces FDA Tentative Approval for Ibuprofen PM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... office buildings (MOBs) and other outpatient facilities, and who are the most active ... at those questions, Revista and Healthcare Real Estate Insights (HREI) found that outpatient ...
(Date:3/29/2017)... ... March 29, 2017 , ... The assembly of synthetic DNA ... many repetitive steps and often scientists require many different versions of DNA. Therefore, ... results in a lower error rate and cost saving for reagents and consumables. ...
(Date:3/29/2017)... ... ... The Wharton School of the University of Pennsylvania is pleased to announce that ... gift to establish the Ken Moelis and Julie Taffet Moelis Advance Access Program ... for highly-qualified Penn undergraduates whose academic and career interests expand traditional notions of business ...
(Date:3/28/2017)... ... ... many women, getting birth control isn’t as easy as it should be. In fact, millions ... a health care facility or a pharmacy within 60 minutes of where they live. This ... many who are faced with health or personal issues that leave them homebound. To help ...
(Date:3/28/2017)... ... March 29, 2017 , ... ... pharmacist Dr. Isabella Wentz, Pharm.D., FASCP. The program was recently launched on March ... common questions regarding thyroid function. , Dr. Izabella Wentz is a licensed ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 29, 2017  Maxor National Pharmacy Services, LLC ("Maxor"), ... has named Leah Bailey as General Counsel.  Bailey ... the company. With more than 13 years ... years focused on health care, Bailey joins the Maxor ... Prime, Bailey advised the PBM, Specialty, and Mail Order ...
(Date:3/29/2017)... 29, 2017 Varian Medical Systems (NYSE: ... the second quarter of fiscal year 2017 following the close ... release will be followed by a teleconference available to all ... a link to the conference call webcast will be available ... the teleconference call and replay: ...
(Date:3/29/2017)...  Spiral Therapeutics, Inc. today announced the signature ... for the worldwide exclusive rights to Bionure,s lead ... of otolaryngology for aggregate payments of up to ... provides Spiral with the option to license two ... Under the terms of the agreement, Spiral will ...
Breaking Medicine Technology: